Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-b receptor exhibit impaired mammary development and enhanced mammary tumor formation
Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-b receptor exhibit impaired mammary development and enhanced mammary tumor formation
复制标题
DOI:
10.1016/s0002-9440(10)63510-9
复制
发表时间:
2003-10-01
影响因子:
6
通讯作者:
Moses, HL
中科院分区:
文献类型:
--
作者:
Gorska, AE;Jensen, RA;Moses, HL
We have previously shown that expression of a dominant-negative type II transforming growth factor-beta receptor (DNIIR) in mammary epithelium under control of the MMTV promoter/enhancer causes alveolar hyperplasia and differentiation in virgin mice. Here we show that MMTV-DNIIR female mice have accelerated mammary gland differentiation during early pregnancy with impaired development during late pregnancy and lactation followed by delayed postlactational involution. Mammary tumors, mostly carcinoma in situ, developed spontaneously in the MMTV-DNIIR mice with a long median latency (27.5 months). Crossbreeding to MMTV-transforming growth factor (TGF)-alpha mice to obtain mice expressing both transgenes resulted in mammary tumor formation with a much shorter latency more similar to those expressing only the MMTV-TGF-alpha transgene (